Cargando…

Point-of-Care Testing for Infectious Diseases Based on Class 2 CRISPR/Cas Technology

The early detection of infectious diseases and microorganisms is critical for effective disease treatment, control, and prevention. Currently, nucleic acid testing and antigen–antibody serum reaction are the two methods most commonly used for the detection of infectious diseases. The former is highl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Shiu-Jau, Rai, Chung-I, Wang, Shao-Cheng, Chen, Yuan-Chuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340307/ https://www.ncbi.nlm.nih.gov/pubmed/37443646 http://dx.doi.org/10.3390/diagnostics13132255

Ejemplares similares

CRISPR-Cas Technology: Emerging Applications in Clinical Microbiology and Infectious Diseases
por: Serajian, Sahar, et al.
Publicado: (2021)

CRISPR/Cas System: A Potential Technology for the Prevention and Control of COVID-19 and Emerging Infectious Diseases
por: Ding, Ronghua, et al.
Publicado: (2021)

Nanotechnology Powered CRISPR-Cas Systems for Point of Care Diagnosis and Therapeutic
por: Li, Chen-zhong, et al.
Publicado: (2022)

CRISPR-Cas systems for diagnosing infectious diseases
por: Kostyusheva, Anastasiya, et al.
Publicado: (2022)

CRISPR/Cas12-Based Ultra-Sensitive and Specific Point-of-Care Detection of HBV
por: Ding, Ronghua, et al.
Publicado: (2021)

Not all predicted CRISPR–Cas systems are equal: isolated cas genes and classes of CRISPR like elements
por: Zhang, Quan, et al.
Publicado: (2017)

CRISPR-Cas Technology In and Out of the Classroom
por: Dahlberg, Lina, et al.
Publicado: (2018)

Applications of CRISPR-Cas Technologies to Proteomics
por: Dolgalev, Georgii, et al.
Publicado: (2021)

The rapidly advancing Class 2 CRISPR‐Cas technologies: A customizable toolbox for molecular manipulations
por: Wang, Jingyi, et al.
Publicado: (2020)

Elimination of infectious HIV DNA by CRISPR–Cas9
por: Das, Atze T, et al.
Publicado: (2019)

Current advances of CRISPR-Cas technology in cell therapy
por: Qiu, Hou-Yuan, et al.
Publicado: (2022)

Novel Antiviral Strategies in the Treatment of COVID-19: A Review
por: Chen, Shiu-Jau, et al.
Publicado: (2020)

Potential Therapeutic Approaches Against Brain Diseases Associated with Cytomegalovirus Infections
por: Wang, Shao-Cheng, et al.
Publicado: (2020)

Antiviral Agents as Therapeutic Strategies Against Cytomegalovirus Infections
por: Chen, Shiu-Jau, et al.
Publicado: (2019)

The Immunotherapy for Colorectal Cancer, Lung Cancer and Pancreatic Cancer
por: Chen, Shiu-Jau, et al.
Publicado: (2021)

Challenges, Recent Advances and Perspectives in the Treatment of Human Cytomegalovirus Infections
por: Chen, Shiu-Jau, et al.
Publicado: (2022)

The CRISPR-Cas system as a tool for diagnosing and treating infectious diseases
por: Lou, Juan, et al.
Publicado: (2022)

Application of CRISPR/Cas Systems in the Nucleic Acid Detection of Infectious Diseases
por: Li, Junwei, et al.
Publicado: (2022)

Application of CRISPR/Cas9 Technology to HBV
por: Lin, Guigao, et al.
Publicado: (2015)

CRISPR/Cas Technologies and Their Applications in Escherichia coli
por: Dong, Huina, et al.
Publicado: (2021)

CRISPR/Cas Technology Revolutionizes Crop Breeding
por: Tang, Qiaoling, et al.
Publicado: (2023)

CRISPR/Cas9 Technology and Its Utility for Crop Improvement
por: Liu, Hua, et al.
Publicado: (2022)

Highly sensitive and rapid point-of-care testing for HIV-1 infection based on CRISPR-Cas13a system
por: Li, Xiaohui, et al.
Publicado: (2023)

Point-of-care CRISPR/Cas nucleic acid detection: Recent advances, challenges and opportunities
por: van Dongen, Jeanne E., et al.
Publicado: (2020)

Point-of-care detection of Neisseria gonorrhoeae based on RPA-CRISPR/Cas12a
por: Tu, Qianrong, et al.
Publicado: (2023)

CRISPR/Cas-Assisted Colorimetric Biosensor for Point-of-Use Testing for African Swine Fever Virus
por: Ki, Jisun, et al.
Publicado: (2022)

Multiplex Molecular Point-of-Care Test for Syndromic Infectious Diseases
por: Kim, Hanbi, et al.
Publicado: (2021)

Detection of Infectious Viruses Using CRISPR-Cas12-Based Assay
por: Talwar, Chandana S., et al.
Publicado: (2021)

Recent advances in the use of the CRISPR-Cas system for the detection of infectious pathogens
por: GAO, Hongdan, et al.
Publicado: (2022)

Targeted genomic rearrangements using CRISPR/Cas technology
por: Choi, Peter S., et al.
Publicado: (2014)

Disruptive Technology: CRISPR/Cas-Based Tools and Approaches
por: Patsali, Petros, et al.
Publicado: (2019)

CRISPR/Cas Technology in Pig-to-Human Xenotransplantation Research
por: Ryczek, Natalia, et al.
Publicado: (2021)

Recent Advances in CRISPR-Cas Technologies for Synthetic Biology
por: Jeong, Song Hee, et al.
Publicado: (2023)

Potential Application of the CRISPR/Cas9 System against Herpesvirus Infections
por: Chen, Yuan-Chuan, et al.
Publicado: (2018)

Advancements in the synergy of isothermal amplification and CRISPR-cas technologies for pathogen detection
por: Mao, Xiaolei, et al.
Publicado: (2023)

Aptasensors for the detection of infectious pathogens: design strategies and point-of-care testing
por: Chen, Xiao-Fei, et al.
Publicado: (2022)

Optimized knock-in of point mutations in zebrafish using CRISPR/Cas9
por: Prykhozhij, Sergey V, et al.
Publicado: (2018)

Optimized knock-in of point mutations in zebrafish using CRISPR/Cas9
por: Prykhozhij, Sergey V, et al.
Publicado: (2018)

Application of nanodiagnostics in point-of-care tests for infectious diseases
por: Wang, Yongzhong, et al.
Publicado: (2017)

Point of care testing for infectious disease: ownership and quality
por: Lisby, Jan Gorm, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ishk0d4s6l3piq5bo92jj68k7r